Anastrozole is a non-steroidal aromatase inhibitor primarily used to treat and prevent hormone receptor-positive breast cancer in postmenopausal women by blocking estrogen synthesis. Pharmaceutical laboratories… Read more

















































Anastrozole is a non-steroidal aromatase inhibitor primarily used to treat and prevent hormone receptor-positive breast cancer in postmenopausal women by blocking estrogen synthesis. Pharmaceutical laboratories require high-quality reference standards of the parent drug and its related compounds to maintain strict quality control and regulatory compliance. This collection includes comprehensive pharmacopeial and non-pharmacopeial impurities, synthetic intermediates, and degradation products, all of which are essential for robust impurity profiling and analytical method validation. Researchers utilize these materials for forced degradation studies, routine batch release testing, and method optimization. Furthermore, the inclusion of stable isotope labelled compounds provides critical internal standards for accurate quantitative analysis during mass spectrometry workflows. By employing these analytically validated reference standards, laboratories can ensure the integrity of their pharmaceutical testing processes across all development and production stages.